184 related articles for article (PubMed ID: 37886910)
1. A new Caenorhabditis elegans model to study copper toxicity in Wilson disease.
Catalano F; O'Brien TJ; Mekhova AA; Sepe LV; Elia M; De Cegli R; Gallotta I; Santonicola P; Zampi G; Ilyechova EY; Romanov AA; Samuseva PD; Salzano J; Petruzzelli R; Polishchuk EV; Indrieri A; Kim BE; Brown AEX; Puchkova LV; Di Schiavi E; Polishchuk RS
Traffic; 2024 Jan; 25(1):e12920. PubMed ID: 37886910
[TBL] [Abstract][Full Text] [Related]
2. A systems biology approach reveals new endoplasmic reticulum-associated targets for the correction of the ATP7B mutant causing Wilson disease.
Concilli M; Iacobacci S; Chesi G; Carissimo A; Polishchuk R
Metallomics; 2016 Sep; 8(9):920-930. PubMed ID: 27714068
[TBL] [Abstract][Full Text] [Related]
3. Identification of p38 MAPK and JNK as new targets for correction of Wilson disease-causing ATP7B mutants.
Chesi G; Hegde RN; Iacobacci S; Concilli M; Parashuraman S; Festa BP; Polishchuk EV; Di Tullio G; Carissimo A; Montefusco S; Canetti D; Monti M; Amoresano A; Pucci P; van de Sluis B; Lutsenko S; Luini A; Polishchuk RS
Hepatology; 2016 Jun; 63(6):1842-59. PubMed ID: 26660341
[TBL] [Abstract][Full Text] [Related]
4. An αB-Crystallin Peptide Rescues Compartmentalization and Trafficking Response to Cu Overload of ATP7B-H1069Q, the Most Frequent Cause of Wilson Disease in the Caucasian Population.
Allocca S; Ciano M; Ciardulli MC; D'Ambrosio C; Scaloni A; Sarnataro D; Caporaso MG; D'Agostino M; Bonatti S
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954118
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the most frequent ATP7B mutation causing Wilson disease in hepatocytes from patient induced pluripotent stem cells.
Parisi S; Polishchuk EV; Allocca S; Ciano M; Musto A; Gallo M; Perone L; Ranucci G; Iorio R; Polishchuk RS; Bonatti S
Sci Rep; 2018 Apr; 8(1):6247. PubMed ID: 29674751
[TBL] [Abstract][Full Text] [Related]
6. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.
Concilli M; Petruzzelli R; Parisi S; Catalano F; Sirci F; Napolitano F; Renda M; Galietta LJV; Di Bernardo D; Polishchuk RS
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32453-32463. PubMed ID: 33288711
[TBL] [Abstract][Full Text] [Related]
7. Activation of Autophagy, Observed in Liver Tissues From Patients With Wilson Disease and From ATP7B-Deficient Animals, Protects Hepatocytes From Copper-Induced Apoptosis.
Polishchuk EV; Merolla A; Lichtmannegger J; Romano A; Indrieri A; Ilyechova EY; Concilli M; De Cegli R; Crispino R; Mariniello M; Petruzzelli R; Ranucci G; Iorio R; Pietrocola F; Einer C; Borchard S; Zibert A; Schmidt HH; Di Schiavi E; Puchkova LV; Franco B; Kroemer G; Zischka H; Polishchuk RS
Gastroenterology; 2019 Mar; 156(4):1173-1189.e5. PubMed ID: 30452922
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.
van den Berghe PV; Stapelbroek JM; Krieger E; de Bie P; van de Graaf SF; de Groot RE; van Beurden E; Spijker E; Houwen RH; Berger R; Klomp LW
Hepatology; 2009 Dec; 50(6):1783-95. PubMed ID: 19937698
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Wilson disease mutations revealed that interactions between different ATP7B mutants modify their properties.
Roy S; McCann CJ; Ralle M; Ray K; Ray J; Lutsenko S; Jayakanthan S
Sci Rep; 2020 Aug; 10(1):13487. PubMed ID: 32778786
[TBL] [Abstract][Full Text] [Related]
10. The plant decapeptide OSIP108 prevents copper-induced toxicity in various models for Wilson disease.
Spincemaille P; Pham DH; Chandhok G; Verbeek J; Zibert A; Libbrecht L; Schmidt H; Esguerra CV; de Witte PA; Cammue BP; Cassiman D; Thevissen K
Toxicol Appl Pharmacol; 2014 Oct; 280(2):345-51. PubMed ID: 25134866
[TBL] [Abstract][Full Text] [Related]
11. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent stem cell-derived bile canaliculi-forming hepatocytes to study genetic liver diseases involving hepatocyte polarity.
Overeem AW; Klappe K; Parisi S; Klöters-Planchy P; Mataković L; du Teil Espina M; Drouin CA; Weiss KH; van IJzendoorn SCD
J Hepatol; 2019 Aug; 71(2):344-356. PubMed ID: 30965071
[TBL] [Abstract][Full Text] [Related]
13. Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease.
Muchenditsi A; Talbot CC; Gottlieb A; Yang H; Kang B; Boronina T; Cole R; Wang L; Dev S; Hamilton JP; Lutsenko S
Sci Rep; 2021 Mar; 11(1):5659. PubMed ID: 33707579
[TBL] [Abstract][Full Text] [Related]
14. ATP7B-Deficient Hepatocytes Reveal the Importance of Protein Misfolding Induced at Low Copper Concentration.
Charbonnier P; Chovelon B; Ravelet C; Ngo TD; Chevallet M; Deniaud A
Cells; 2022 Oct; 11(21):. PubMed ID: 36359796
[TBL] [Abstract][Full Text] [Related]
15. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations.
Ariöz C; Li Y; Wittung-Stafshede P
Biometals; 2017 Dec; 30(6):823-840. PubMed ID: 29063292
[TBL] [Abstract][Full Text] [Related]
16. Human copper transporter ATP7B (Wilson disease protein) forms stable dimers
Jayakanthan S; Braiterman LT; Hasan NM; Unger VM; Lutsenko S
J Biol Chem; 2017 Nov; 292(46):18760-18774. PubMed ID: 28842499
[TBL] [Abstract][Full Text] [Related]
17. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.
Chandhok G; Horvath J; Aggarwal A; Bhatt M; Zibert A; Schmidt HH
World J Gastroenterol; 2016 Apr; 22(16):4109-19. PubMed ID: 27122662
[TBL] [Abstract][Full Text] [Related]
19. Polarized trafficking and copper transport activity of ATP7B: A mutational approach to establish genotype-phenotype correlation in Wilson disease.
Das S; Mohammed A; Mandal T; Maji S; Verma J; Ruturaj ; Gupta A
Hum Mutat; 2022 Oct; 43(10):1408-1429. PubMed ID: 35762218
[TBL] [Abstract][Full Text] [Related]
20. Clusterin (apolipoprotein J), a molecular chaperone that facilitates degradation of the copper-ATPases ATP7A and ATP7B.
Materia S; Cater MA; Klomp LW; Mercer JF; La Fontaine S
J Biol Chem; 2011 Mar; 286(12):10073-83. PubMed ID: 21242307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
